Scilex Holding Company, a majority-owned subsidiary of
ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in...
Source: globenewswire.com
Mathangi Gopalakrishnan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mathangi Gopalakrishnan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mathangi Gopalakrishnan Today - Breaking & Trending Today
Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response
A new review of antipsychotic trials finds that the placebo response rate is steadily increasing and drug response is decreasing.
Source: madinamerica.com